pyridazine has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makala, H; Ulaganathan, V | 1 |
| Bihel, F; Bourguignon, JJ; El-Etrawy, ASh; Elagawany, M; Ghiaty, A; Hamel, E; Ibrahim, MA; Nguyen, TL; Pessoa, C; Sbardelotto, AB; Schmitt, M | 1 |
| Abouzid, K; Jaballah, MY; Serya, RT | 1 |
1 review(s) available for pyridazine and Benign Neoplasms
| Article | Year |
|---|---|
Pyridazine Based Scaffolds as Privileged Structures in anti-Cancer Therapy.
Topics: Antineoplastic Agents; Drug Design; Humans; Neoplasms; Protein Kinase Inhibitors; Pyridazines; Signal Transduction | 2017 |
2 other study(ies) available for pyridazine and Benign Neoplasms
| Article | Year |
|---|---|
Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.
Topics: Allosteric Site; Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Humans; Kinesins; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Protein Binding; Protein Conformation; Pyridazines | 2018 |
Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Neoplasms; Pyridazines; Stilbenes; Tubulin | 2013 |